Key result
Community-acquired pneumonia in patients with coronary heart disease significantly increased baseline hs-CRP levels to 8.0 mg/L compared to 3.9 mg/L in patients without pneumonia.
Why the study?
Does community-acquired pneumonia increase systemic inflammation markers and worsen the clinical course of coronary heart disease?
Cohort (n=90)
Open-label
No
Does community-acquired pneumonia increase systemic inflammation markers and worsen the clinical course of coronary heart disease?
Absolute Event Rate: 8% vs 3.9%
p-value: p=<0.05
Elevated levels of systemic inflammation markers (hs-CRP, neopterin, PAPP-A) in patients with coronary heart disease following community-acquired pneumonia are associated with a worse clinical prognosis over 1 year.
Pneumonia-linked hs-CRP rises may flag higher-risk CHD patients; hypothesis-generating and requires trials before guiding care.
Extensive research has established that community acquired pneumonia has negative impact on clinical course on coronary heart disease (CHD), but the pathogenic mechanism was not understood.Aim. To study the pro-inflammatory biomarkers and endothelial dysfunction, its interrelation with CHD clinical course in patients with community acquired pneumonia, 90 patients were recruited.Methods and results. The I (main) subcohort included 60 CHD patients with community acquired pneumonia, the II subcohort included 30 stable angina pectoris without community acquired pneumonia and 21 community acquired pneumonia patients, ІІІ clinical group – without CHD. Using immunoassay high-sensitive C-reactive protein, neopterine and pregnancy-associated protein A were assessed. Among patients with CHD and community acquired pneumonia the significant increasing of all biomarkers was observed at the beginning and after 1 month of disease. The increasing of these biomarkers was associated with was associated with poorer prognosis in CHD patients during 1 year follow-up. Conclusions. The direct correlation between high-sensitive C-reactive protein and neopterine, РАРР-А was found, which suggests the pathogenic ties between immune inflammation and endothelial dysfunction among patients with CHD and community acquired pneumonia.
No takes yet. Share an insight, caveat, or question.
Mykhailovska et al. (2015) conducted a cohort in Coronary heart disease and community-acquired pneumonia (n=90). Community-acquired pneumonia (exposure) vs. Coronary heart disease without community-acquired pneumonia was evaluated on High-sensitive C-reactive protein (hs-CRP) level at baseline (mg/L) (p=<0.05). Community-acquired pneumonia in patients with coronary heart disease significantly increased baseline hs-CRP levels to 8.0 mg/L compared to 3.9 mg/L in patients without pneumonia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: